ABOUT LUCENTIS|RESULTS WITH LUCENTIS
Results with LUCENTIS® (ranibizumab injection)
LUCENTIS is an FDA-approved treatment for wet age-related macular degeneration (AMD).
During key clinical studies lasting 2 years, people taking LUCENTIS monthly saw the following results:
- 9 out of 10 patients saw their vision stabilize
- Up to 4 out of 10 people saw a 3-line gain on the eye chart, which means they could see an additional 15 letters
- A few people did have some vision loss
Everyone responds differently to LUCENTIS, and some people see results faster than others. Even if your vision stabilizes with LUCENTIS, you may still need to continue with regular treatment. Also, you may not see results right away. But don't get discouraged. You may see changes over time.

















